Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Summary: Langerhans cell histiocytosis (LCH), the most common histiocytic disorder, is characterized by the accumulation of CD1A+/CD207+ mononuclear phagocytes within granulomatous lesions that can affect nearly all organ systems. Historically, LCH has been presumed to arise from transformed or pathologically activated epidermal dendritic cells called Langerhans cells. However, new evidence supports a model in which LCH occurs as a consequence of a misguided differentiation programme of myeloid dendritic cell precursors. Genetic, molecular and functional data implicate activation of the ERK signalling pathway at critical stages in myeloid differentiation as an essential and universal driver of LCH pathology. Based on these findings, we propose that LCH should be re‐defined as an inflammatory myeloid neoplasia. Increased understanding of LCH pathogenesis will provide opportunities to optimize and personalize therapy through improved risk‐stratification, targeted therapy and assessment of therapy response based on specific molecular features and origin of the pathological myeloid cells.
Funding Information
  • Institut National de la Santé et de la Recherche Médicale (CA154489)
  • Institut National de la Santé et de la Recherche Médicale (CA1CA54947A)
  • Institut National de la Santé et de la Recherche Médicale (AI10008)
  • Institut National de la Santé et de la Recherche Médicale (AI089987)
  • Deutsche Forschungsgemeinschaft (BE 4818/1-1)
  • Deutsche Forschungsgemeinschaft (SFB TRR57 P07)

This publication has 91 references indexed in Scilit: